-
SynBERC hosts symposium on synbio ownership, sharing & innovationThe first SynBiOSIS (Synthetic Biology Ownership, Sharing & Innovation Symposium) will be held at Stanford University on January 27-28, 2012, bringing together leading experts in intellectual property law and representatives from across various institutions who are facing property rights challenges in the development of tools and applications of synthetic biology. - Ron Weiss puts genetic engineering on steroidsScience Magazine profiles Ron Weiss, including his early skepticism of the "messy" life sciences, the sometimes awkward transition from electrical to biological engineering, and his current role as director of MIT’s Synthetic Biology Center, where he endeavors to reprogram cells.
-
SynBERC releases updated guide to synthetic biology regulation in US and EUA team lead by SynBERC Practices investigator Ken Oye has produced an updated and expanded version of its Guide to the Regulation of Synthetic Biology in the US & EU. First published in 2010, the guide surveys how existing regulations apply to the emerging field of synthetic biology. -
CAD tools for RNA devices enable better engineering of biological systemsSynBERC researchers have developed CAD-type tools for engineering RNA components that hold enormous potential for microbial-based production of advanced biofuels and other goods now derived from petrochemicals. - SynBERC-Siebel Scholars Forum focuses on challenges to commercializing synbioA group of academics, industry members, business community leaders, and Siebel Scholars from across the Bay Area came together to share best practices and discuss the technical, economic, and social challenges to pursuing synthetic biology.
-
Modifying the language of lifeSynBERC researchers at Harvard are a step closer to engineering new words in the DNA language of bacteria by co-opting one of the codons in its genetic code to give it new meaning. -
DNA2.0 partners with BIOFAB to offer biological partsDNA2.0 announced that the first collection of biological building blocks characterized by the BIOFAB International Open Facility Advancing Biotechnology (BIOFAB) are now available for use in the design and assembly of genes within DNA2.0’s Gene Designer software. The free-to-use BIOFAB genetic parts are distributed as virtual sequences in the newly minted gene marketplace embedded within DNA2.0’s gene design and assembly application.









